Regen BioPharma (RGBPP) Competitor Comparison
We are evaluating the key criteria listed to compare Regen BioPharma (RGBPP) against its competitors in the Biotechnology industry.
Market Capitalization
253 / 368Gross Profits
141 / 278Total Revenue
268 / 300EBITDA
0 / 337Free Cashflow
49 / 352Quick Ratio
356 / 357Earnings per Share
41 / 359Dividend yield
0 / 6Total Cash
356 / 358Performance 3 years
362 / 368Performance 5 years
317 / 368Performance 10 years
263 / 368Linearity 3 years
258 / 368Linearity 5 years
102 / 368Linearity 10 years
325 / 368Total Rank
245 / 368Dividend Rank
258 / 368Valuation Rank
294 / 368Piotroski Rank
155 / 368Muliplier Rank
191 / 368Performance 10 years - RGBPP ranking 263 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.